Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

9.48
Delayed Data
As of Sep 03
 -0.05 / -0.52%
Today’s Change
1.86
Today|||52-Week Range
19.68
+79.55%
Year-to-Date
No recent news for InVivo Therapeutics Holdings Corp.

Today’s Trading

Previous close9.53
Today’s open9.51
Day’s range9.40 - 9.86
Volume149,244
Average volume (3 months)452,335
Market cap$257.3M
Dividend yield--
Data as of 09/03/2015

Growth & Valuation

Earnings growth (last year)+59.62%
Earnings growth (this year)+21.25%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book37.77

Competitors

 Today’s
change
Today’s
% change
RKDAArcadia Biosciences ...-0.38-6.44%
ZYNEZynerba Pharmaceutic...-1.26-4.19%
PRTOProteon Therapeutics...-0.81-5.50%
QLTIQLT Inc-0.08-2.33%
Data as of 09/03/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$0.00
Annual profit (last year)-$18.3M
Net profit margin--

Profile

Sector
Industrial Services
Industry
Engineering & Construction
Chief Executive Officer &
Director
Mark D. Perrin
Senior Vice President-
Operations
William D'Agostino
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers